Bone growth oscillation: longitudinal metabolic process of bone growth in congenital adrenal hyperplasia and

O Arisaka1, H Kanno, M Negishi

  • 1Department of Pediatrics, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.

Insights

Serum osteocalcin (OC) levels in children with congenital adrenal hyperplasia (CAH) showed variable bone growth, unlike those with nonendocrine short stature (NESS) who had stable bone growth. Further research is needed to understand these metabolic differences.

Area of Science:

  • Pediatric Endocrinology
  • Bone Metabolism Research
  • Biochemical Markers in Growth

Background:

  • Understanding bone growth in children is crucial for identifying growth disorders.
  • Serum osteocalcin (OC) is a key marker for bone metabolism.
  • Congenital adrenal hyperplasia (CAH) and nonendocrine short stature (NESS) present distinct growth patterns.

Purpose of the Study:

  • To investigate the longitudinal relationship between serum osteocalcin (OC) levels and growth velocity in prepubertal children.
  • To compare the metabolic bone growth processes in children with CAH versus NESS.
  • To explore potential differences in bone metabolism variability.

Main Methods:

  • Longitudinal observation of 10 prepubertal CAH patients and 9 prepubertal NESS patients over 7 years.
  • Bi-annual measurements of serum osteocalcin (OC) levels.
  • Monitoring of growth velocity throughout the study period.

Main Results:

  • Patients with CAH displayed wide fluctuations in both growth velocity and serum OC levels, indicating variable bone metabolism.
  • Patients with NESS showed stable growth velocity and consistently narrow-range serum OC levels, suggesting stable bone metabolism.
  • A clear divergence in bone metabolic processes was observed between the two groups.

Conclusions:

  • Children with CAH exhibit metabolically variable bone growth, contrasting with the stable bone growth seen in NESS patients.
  • The observed differences in bone metabolism between CAH and NESS warrant further investigation.
  • Future research should explore the relationship between these metabolic processes and bone structure or density.

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...